Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amarin Corporation plc

Market Cap 320M 276M 255M 238M 447M 30.39B 454M 3.02B 1.17B 14.78B 1.2B 1.17B 51.19B P/E Ratio 2026 *
-435x
P/E Ratio 2027 * 277x
Enterprise Value 146M 126M 116M 109M 204M 13.86B 207M 1.37B 535M 6.74B 547M 535M 23.34B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.68x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.28%
1 week+9.40%
Current month+5.18%
1 month+1.94%
3 months-6.90%
6 months+6.13%
Current year+9.21%
1 week 13.92
Extreme 13.92
15.54
1 month 13.6
Extreme 13.6
15.54
Current year 12.96
Extreme 12.96
17.31
1 year 12.3
Extreme 12.3
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap.
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+2.28%+9.40%+13.90%-40.00% 320M
+1.03%+2.30%+54.92%+111.78% 56.42B
+2.72%+3.26%+47.26%+47.26% 44.54B
+1.12%+2.79%-13.71%-17.53% 22.9B
+1.17%+3.85%+1.00%+401.79% 21.21B
+3.81%-5.07%+12.00%-29.52% 16.4B
+0.15%+2.24%+9.10%-40.04% 15.4B
-0.69%+0.82%+27.17%+178.31% 13.35B
+5.27%+5.54%+14.25% - 12.36B
+1.61%+1.28%+92.88%+215.31% 11.15B
Average +1.85%+2.82%+25.88%+91.93% 21.4B
Weighted average by Cap. +1.72%+2.38%+31.90%+100.16%

Financials

2026 *2027 *
Net sales 182M 158M 145M 136M 255M 17.33B 259M 1.72B 669M 8.43B 684M 669M 29.19B 193M 167M 154M 144M 270M 18.35B 274M 1.82B 708M 8.92B 724M 709M 30.9B
Net income -15.02M -12.99M -11.96M -11.21M -21.02M -1.43B -21.33M -142M -55.16M -695M -56.38M -55.18M -2.41B 22.13M 19.13M 17.63M 16.51M 30.96M 2.1B 31.42M 209M 81.27M 1.02B 83.05M 81.28M 3.55B
Net Debt -174M -150M -138M -130M -243M -16.53B -247M -1.64B -638M -8.04B -652M -639M -27.85B -187M -162M -149M -140M -262M -17.83B -266M -1.77B -688M -8.67B -704M -689M -30.03B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
12/06/26 15.24 $ +2.28% 76,197
11/06/26 14.90 $ +0.95% 50,777
10/06/26 14.76 $ -0.87% 81,202
09/06/26 14.89 $ +4.86% 180,740
08/06/26 14.20 $ +1.94% 82,124
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
15.24USD
Average target price
12.50USD
Spread / Average Target
-17.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!